FibroBiologics Inc. Commo... (FBLG)
NASDAQ: FBLG
· Real-Time Price · USD
0.57
-0.02 (-3.23%)
At close: Aug 20, 2025, 3:59 PM
0.57
-0.60%
After-hours: Aug 20, 2025, 07:33 PM EDT
FibroBiologics Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Revenue | 554K | 554K | 554K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 359K | 293K | 430K | 407K | 519K | 379K | 338K | 208K | 96K | 96K | n/a | n/a | n/a | n/a |
Gross Profit | 71K | 137K | n/a | -407K | -519K | -379K | -338K | -208K | -96K | -96K | n/a | n/a | n/a | n/a |
Operating Income | -16.09M | -14.82M | -13.74M | -12.51M | -11.21M | -10.07M | -8.89M | -7.71M | -7M | -5.82M | -4.47M | -3.16M | -1.82M | -911K |
Interest Income | 291K | 311K | 251K | 188K | 109K | 39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.22M | -7.67M | -11.16M | -17.78M | -19.47M | -22.53M | -16.48M | -8.29M | -7.66M | -6.52M | -5.12M | -3.6M | -2.04M | -1.02M |
Net Income | -13.22M | -7.67M | -11.16M | -17.78M | -19.47M | -22.53M | -16.48M | -8.29M | -7.66M | -6.52M | -5.12M | -3.6M | -2.04M | -1.02M |
Selling & General & Admin | 9.49M | 9.49M | 9.13M | 8.38M | 7.62M | 6.92M | 6.23M | 5.58M | 5.19M | 4.33M | 3.32M | 2.36M | 1.37M | 684K |
Research & Development | 6.34M | 5.24M | 4.38M | 3.82M | 3.17M | 2.77M | 2.32M | 1.93M | 1.71M | 1.4M | 1.15M | 802K | 454K | 227K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -15K | -15K | -15K | -15K | n/a | n/a | n/a | n/a |
Operating Expenses | 15.73M | 14.67M | 13.45M | 12.24M | 10.83M | 9.7M | 8.55M | 7.5M | 6.91M | 5.72M | 4.47M | 3.16M | 1.82M | 911K |
Interest Expense | 11K | 16K | 20K | 15K | 10K | 16K | 147K | 366K | 587K | 576K | 441K | 221K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -102K | -201K | -300K | -300K | -293K | 198K | 297K | 297K | 392K | n/a | n/a | n/a |
Cost & Expenses | 16.09M | 14.82M | 13.74M | 12.51M | 11.21M | 10.07M | 8.89M | 7.71M | 7M | 5.82M | 4.47M | 3.16M | 1.82M | 911K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -46K | -46K | -46K | -46K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 38.64M | 36.67M | 32.88M | 33.52M | 32.72M | 32.72M | 28.23M | 32.49M | 32.48M | 32.72M | 28.23M | 32.49M | 28.23M | 28.23M |
Shares Outstanding (Diluted) | 38.64M | 36.67M | 32.88M | 33.52M | 32.72M | 32.72M | 28.23M | 32.49M | 32.48M | 32.72M | 28.23M | 32.49M | 28.23M | 28.23M |
EPS (Basic) | -0.37 | -0.22 | -0.34 | -0.59 | -0.64 | -0.73 | -0.55 | -0.26 | -0.24 | -0.21 | -0.17 | -0.12 | -0.07 | -0.04 |
EPS (Diluted) | -0.37 | -0.22 | -0.34 | -0.59 | -0.64 | -0.73 | -0.55 | -0.26 | -0.24 | -0.21 | -0.17 | -0.12 | -0.07 | -0.04 |
EBITDA | -12.55M | -7.05M | -10.57M | -17.21M | -18.94M | -22.04M | -15.9M | -7.53M | -6.79M | -4.74M | -2.55M | -1.34M | n/a | n/a |
EBIT | -13.21M | -7.65M | -11.14M | -17.76M | -19.46M | -22.51M | -16.34M | -7.93M | -7.08M | -5.84M | -4.47M | -3.16M | -1.82M | -911K |
Depreciation & Amortization | 663K | 597K | 573K | 550K | 519K | 478K | 437K | 1.61M | 1.5M | 2.31M | 3.13M | 1.82M | 1.82M | 911K |